| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.002 | 0.86 | Estrogen antagonist | 0.798 0.003 CID_3035212 | ||
| 0.609 | 0.012 | 0.609 | Spasmolytic | 0.53 0.02 CID_3035212 | ||
| 0.583 | 0.009 | 0.583 | DNA damaging | 0.578 0.009 CID_3035212 | ||
| 0.555 | 0.01 | 0.555 | Vasodilator, coronary | 0.515 0.014 CID_3035212 | ||
| 0.48 | 0.004 | 0.48 | Estrogen agonist | 0.392 0.004 CID_3035212 | ||
| 0.495 | 0.034 | 0.495 | Aldehyde oxidase inhibitor | |||
| 0.491 | 0.063 | 0.491 | Caspase 9 stimulant | 0.386 0.119 CID_3035212 | ||
| 0.408 | 0.004 | 0.408 | Estrogen receptor beta antagonist | 0.317 0.005 CID_3035212 | ||
| 0.398 | 0.001 | 0.398 | Estrogen-related receptor beta antagonist | 0.305 0.001 CID_3035212 | ||
| 0.414 | 0.021 | 0.414 | Vasodilator | 0.383 0.026 CID_3035212 | ||
| 0.385 | 0.01 | 0.385 | Bone formation stimulant | 0.347 0.013 CID_3035212 | ||
| 0.381 | 0.019 | 0.381 | Anesthetic general | 0.256 0.048 CID_3035212 | ||
| 0.329 | 0.005 | 0.329 | Estrogen receptor alpha antagonist | 0.143 0.013 CID_3035212 | ||
| 0.333 | 0.01 | 0.34 | Growth factor agonist | 0.34 0.009 CID_3035212 | CID_3035212 | |
| 0.289 | 0.006 | 0.292 | 5 Hydroxytryptamine 3E antagonist | 0.292 0.005 CID_3035212 | CID_3035212 | |
| 0.277 | 0.002 | 0.277 | Estrogen-related receptor beta agonist | 0.169 0.003 CID_3035212 | ||
| 0.389 | 0.119 | 0.392 | Apoptosis agonist | 0.392 0.118 CID_3035212 | CID_3035212 | |
| 0.274 | 0.015 | 0.274 | Anesthetic local | 0.228 0.025 CID_3035212 | ||
| 0.224 | 0.02 | 0.224 | Alkylator | 0.22 0.021 CID_3035212 | ||
| 0.204 | 0.008 | 0.21 | Thioredoxin inhibitor | 0.21 0.007 CID_3035212 | CID_3035212 | |
| 0.199 | 0.011 | 0.199 | Phosphodiesterase I inhibitor | 0.097 0.048 CID_3035212 | ||
| 0.195 | 0.007 | 0.195 | Phosphodiesterase 4A inhibitor | 0.131 0.011 CID_3035212 | ||
| 0.275 | 0.093 | 0.275 | Caspase 3 stimulant | 0.249 0.113 CID_3035212 | ||
| 0.201 | 0.023 | 0.203 | Alpha 2b adrenoreceptor antagonist | 0.203 0.023 CID_3035212 | CID_3035212 | |
| 0.186 | 0.015 | 0.186 | Telomerase inhibitor | 0.122 0.026 CID_3035212 | ||
| 0.178 | 0.007 | 0.178 | Anabolic | 0.16 0.013 CID_3035212 | ||
| 0.2 | 0.042 | 0.2 | Acetylcholine M1 receptor antagonist | 0.145 0.079 CID_3035212 | ||
| 0.169 | 0.018 | 0.169 | Sphingomyelinase inhibitor | 0.133 0.033 CID_3035212 | ||
| 0.192 | 0.041 | 0.192 | Arachidonic acid antagonist | 0.133 0.109 CID_3035212 | ||
| 0.172 | 0.034 | 0.172 | DNA intercalator | 0.091 0.084 CID_3035212 | ||
| 0.198 | 0.065 | 0.198 | P-glycoprotein inhibitor | 0.179 0.08 CID_3035212 | ||
| 0.209 | 0.088 | 0.209 | Hypolipemic | 0.177 0.112 CID_3035212 | ||
| 0.161 | 0.04 | 0.169 | Proteasome inhibitor | 0.169 0.036 CID_3035212 | CID_3035212 | |
| 0.132 | 0.015 | 0.142 | Histamine H2 receptor antagonist | 0.142 0.012 CID_3035212 | CID_3035212 | |
| 0.132 | 0.022 | 0.132 | CYP2A6 inhibitor | 0.125 0.025 CID_3035212 | ||
| 0.113 | 0.005 | 0.113 | Estrogen-related receptor alpha antagonist | 0.092 0.007 CID_3035212 | ||
| 0.113 | 0.011 | 0.128 | Beta 3 adrenoreceptor antagonist | 0.128 0.008 CID_3035212 | CID_3035212 | |
| 0.107 | 0.009 | 0.107 | Phosphodiesterase 1C inhibitor | |||
| 0.096 | 0.001 | 0.096 | Estrogen-related receptor gamma antagonist | 0.074 0.002 CID_3035212 | ||
| 0.128 | 0.034 | 0.128 | Alpha 2 adrenoreceptor antagonist | 0.128 0.034 CID_3035212 | ||
| 0.272 | 0.188 | 0.293 | Cyclophilin D inhibitor | 0.293 0.169 CID_3035212 | CID_3035212 | |
| 0.091 | 0.017 | 0.091 | Phosphodiesterase 1B inhibitor | |||
| 0.093 | 0.019 | 0.108 | Phospholipase D inhibitor | 0.108 0.01 CID_3035212 | CID_3035212 | |
| 0.11 | 0.037 | 0.11 | Histamine N-methyltransferase inhibitor | |||
| 0.111 | 0.045 | 0.111 | Prolactin inhibitor | |||
| 0.089 | 0.024 | 0.089 | Aromatase inhibitor | 0.075 0.03 CID_3035212 | ||
| 0.077 | 0.013 | 0.097 | 5 Hydroxytryptamine 1B agonist | 0.097 0.008 CID_3035212 | CID_3035212 | |
| 0.066 | 0.002 | 0.066 | Estrogen-related receptor gamma agonist | 0.054 0.002 CID_3035212 | ||
| 0.08 | 0.017 | 0.08 | Phosphodiesterase 1A inhibitor | |||
| 0.159 | 0.097 | 0.159 | Succinate dehydrogenase inhibitor | 0.152 0.108 CID_3035212 | ||
| 0.127 | 0.068 | 0.127 | Cholinergic antagonist | |||
| 0.193 | 0.135 | 0.193 | DNA synthesis inhibitor | 0.177 0.157 CID_3035212 | ||
| 0.121 | 0.066 | 0.121 | Acetylcholine muscarinic antagonist | |||
| 0.089 | 0.038 | 0.089 | Acetylcholine M4 receptor antagonist | |||
| 0.12 | 0.07 | 0.12 | Acetylcholine antagonist | |||
| 0.076 | 0.027 | 0.076 | Dopamine uptake inhibitor | 0.074 0.028 CID_3035212 | ||
| 0.064 | 0.017 | 0.064 | Squalene epoxidase inhibitor | 0.046 0.043 CID_3035212 | ||
| 0.114 | 0.071 | 0.114 | Cholesterol synthesis inhibitor | |||
| 0.127 | 0.086 | 0.127 | Nav1.6 sodium channel blocker | |||
| 0.053 | 0.014 | 0.053 | GABA uptake inhibitor | |||
| 0.107 | 0.072 | 0.107 | Acetylcholine release stimulant | |||
| 0.169 | 0.134 | 0.169 | ErbB-1 antagonist | |||
| 0.15 | 0.116 | 0.15 | Psychostimulant | |||
| 0.114 | 0.085 | 0.114 | DNA repair enzyme inhibitor | 0.11 0.096 CID_3035212 | ||
| 0.069 | 0.041 | 0.069 | Dopamine D1 antagonist | |||
| 0.085 | 0.059 | 0.085 | Calcium antagonist | |||
| 0.061 | 0.04 | 0.061 | Acetylcholine M5 receptor antagonist | |||
| 0.085 | 0.066 | 0.085 | Triose-phosphate isomerase inhibitor | |||
| 0.111 | 0.094 | 0.111 | Nav1.2 sodium channel blocker | |||
| 0.023 | 0.007 | 0.023 | Antibiotic Anthracycline-like | 0.021 0.009 CID_3035212 | ||
| 0.055 | 0.04 | 0.087 | Beta 1 adrenoreceptor antagonist | 0.087 0.014 CID_3035212 | CID_3035212 | |
| 0.038 | 0.023 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.075 | 0.061 | 0.075 | Acetylcholine nicotinic antagonist | |||
| 0.149 | 0.135 | 0.149 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.144 0.143 CID_3035212 | ||
| 0.071 | 0.06 | 0.071 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.051 | 0.041 | 0.051 | Alpha 1L adrenoreceptor antagonist | |||
| 0.077 | 0.07 | 0.077 | Androgen antagonist | |||
| 0.061 | 0.054 | 0.084 | Beta adrenoreceptor antagonist | 0.084 0.024 CID_3035212 | CID_3035212 | |
| 0.107 | 0.102 | 0.107 | Toll-Like receptor 9 antagonist | |||
| 0.066 | 0.062 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.03 | 0.027 | 0.03 | Glycine transporter 1 inhibitor | |||
| 0.094 | 0.092 | 0.094 | Topoisomerase II inhibitor | |||
| 0.046 | 0.044 | 0.046 | Sodium/calcium exchanger inhibitor | |||
| 0.082 | 0.08 | 0.082 | Aminopeptidase B inhibitor | |||
| 0.05 | 0.058 | 0.131 | Adrenaline uptake inhibitor | 0.131 0.012 CID_3035212 | CID_3035212 | |
| 0.199 | 0.209 | 0.213 | GABA C receptor rho-3 antagonist | 0.213 0.192 CID_3035212 | CID_3035212 | |
| 0.175 | 0.188 | 0.181 | Tyrosine 3 hydroxylase inhibitor | 0.181 0.174 CID_3035212 | CID_3035212 | |
| 0.023 | 0.043 | 0.035 | Melatonin 2 agonist | 0.035 0.02 CID_3035212 | CID_3035212 | |
| 0.13 | 0.161 | 0.146 | Insulin sensitizer | 0.146 0.138 CID_3035212 | CID_3035212 | |
| 0.059 | 0.1 | 0.08 | Antiadrenergic | 0.08 0.071 CID_3035212 | CID_3035212 | |
| 0.033 | 0.083 | 0.091 | 5 Hydroxytryptamine uptake inhibitor | 0.091 0.03 CID_3035212 | CID_3035212 | |
| 0.139 | 0.204 | 0.193 | 5 Hydroxytryptamine release stimulant | 0.193 0.128 CID_3035212 | CID_3035212 | |
| 0.07 | 0.137 | 0.183 | Toll-Like receptor 3 antagonist | 0.183 0.008 CID_3035212 | CID_3035212 | |
| 0.166 | 0.272 | 0.266 | Calcium channel activator | 0.266 0.129 CID_3035212 | CID_3035212 | |
| 0.094 | 0.202 | 0.128 | Adenylate cyclase stimulant | 0.128 0.106 CID_3035212 | CID_3035212 | |
| 0.098 | 0.229 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.133 CID_3035212 | CID_3035212 | |
| 0.058 | 0.227 | 0.092 | Glutamate (mGluR7) agonist | 0.092 0.079 CID_3035212 | CID_3035212 | |
| 0.118 | 0.316 | 0.205 | Peptidyltransferase inhibitor | 0.205 0.093 CID_3035212 | CID_3035212 | |
| 0.115 | 0.535 | 0.482 | Calcium channel L-type activator | 0.482 0.035 CID_3035212 | CID_3035212 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |